BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10477451)

  • 1. In vitro study of the combination gemcitabine + fludarabine on freshly isolated chronic lymphocytic leukemia cells.
    Tosi P; Pellacani A; Zinzani PL; Magagnoli M; Visani G; Tura S
    Haematologica; 1999 Sep; 84(9):794-8. PubMed ID: 10477451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro modulation of bcl-2 protein expression, drug-induced apoptosis and cytotoxicity by interleukin-10 in chronic lymphocytic leukemia.
    Morabito F; Filangeri M; Sculli G; Oliva B
    Haematologica; 1998 Nov; 83(11):1046-8. PubMed ID: 9864930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia.
    Bellosillo B; Villamor N; Colomer D; Pons G; Montserrat E; Gil J
    Blood; 1999 Oct; 94(8):2836-43. PubMed ID: 10515887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
    König A; Menzel T; Lynen S; Wrazel L; Rosén A; Al-Katib A; Raveche E; Gabrilove JL
    Leukemia; 1997 Feb; 11(2):258-65. PubMed ID: 9009090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
    Kano Y; Akutsu M; Tsunoda S; Suzuki K; Ichikawa A; Furukawa Y; Bai L; Kon K
    Leukemia; 2000 Mar; 14(3):379-88. PubMed ID: 10720130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells.
    Romano MF; Lamberti A; Tassone P; Alfinito F; Costantini S; Chiurazzi F; Defrance T; Bonelli P; Tuccillo F; Turco MC; Venuta S
    Blood; 1998 Aug; 92(3):990-5. PubMed ID: 9680368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fludarabine and gemcitabine on human acute myeloid leukemia cell line HL 60: direct comparison of cytotoxicity and cellular Ara-C uptake enhancement.
    Santini V; D'Ippolito G; Bernabei PA; Zoccolante A; Ermini A; Rossi-Ferrini P
    Leuk Res; 1996 Jan; 20(1):37-45. PubMed ID: 8632676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.
    Galmarini CM; Clarke ML; Falette N; Puisieux A; Mackey JR; Dumontet C
    Int J Cancer; 2002 Feb; 97(4):439-45. PubMed ID: 11802204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway.
    Zhou Z; Fang Q; Li P; Ma D; Zhe N; Ren M; Chen B; He Z; Wang J; Zhong Q; Wang J
    Life Sci; 2019 Sep; 232():116583. PubMed ID: 31226417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
    Adams DJ; Levesque MC; Weinberg JB; Smith KL; Flowers JL; Moore J; Colvin OM; Silber R
    Leukemia; 2001 Dec; 15(12):1852-9. PubMed ID: 11753605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Shinn CA; Flinn IW; Byrd JC
    Leuk Res; 2001 Jun; 25(6):435-40. PubMed ID: 11337014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.
    Byrd JC; Shinn C; Waselenko JK; Fuchs EJ; Lehman TA; Nguyen PL; Flinn IW; Diehl LF; Sausville E; Grever MR
    Blood; 1998 Nov; 92(10):3804-16. PubMed ID: 9808574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation.
    Fu C; Shi X; Gong Y; Wan Y; Sun Z; Shi H; Wang Z; Marinaccio C; Crispino JD; Xu K
    Cell Physiol Biochem; 2018; 50(6):2314-2328. PubMed ID: 30423551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro sensitivity of B-CLL cells to fludarabine and interferons.
    Di Raimondo F; Palumbo GA; Romeo MA; Cacciola E; Milone G; Impera S; Giustolisi R; Cacciola E
    Leuk Lymphoma; 1995 May; 17(5-6):449-53. PubMed ID: 7549836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells.
    Ashofteh N; Amini R; Molaee N; Karami H; Baazm M
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2191-2198. PubMed ID: 34319043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity.
    Bruno S; Ghiotto F; Tenca C; Mazzarello AN; Bono M; Luzzi P; Casciaro S; Recchia A; Decensi A; Morabito F; Fais F
    Leukemia; 2012 Oct; 26(10):2260-8. PubMed ID: 22475870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells.
    Tosi P; Zinzani PL; Pellacani A; Ottaviani E; Magagnoli M; Tura S
    Leuk Lymphoma; 1997 Jul; 26(3-4):343-8. PubMed ID: 9322897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective apoptosis due to Bcl-2 overexpression may explain why B-CLL cells accumulate in G0.
    Gottardi D; Alfarano A; De Leo AM; Stacchini A; Bergui L; Caligaris-Cappio F
    Curr Top Microbiol Immunol; 1995; 194():307-12. PubMed ID: 7895503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.